A Pilot Study of an Intensified Ganciclovir Dosing Strategy for Treatment of Cytomegalovirus Disease in Kidney and/or Pancreas Transplant Recipients

2021 ◽  
Author(s):  
Margaret R Jorgenson ◽  
Jillian L Descourouez ◽  
Glen E Leverson ◽  
Christopher M Saddler ◽  
Jeannina A Smith ◽  
...  
Keyword(s):  
Pilot Study ◽  
Pancreas Transplant ◽  
Transplant Recipients ◽  
Cytomegalovirus Disease ◽  
Dosing Strategy

Efficacy of Valganciclovir in the Treatment of Cytomegalovirus Disease in Kidney and Pancreas Transplant Recipients

2006 ◽  
Vol 38 (10) ◽  
pp. 3673-3675 ◽  
Author(s):  
F.L. Luan ◽  
P. Chopra ◽  
J. Park ◽  
S. Norman ◽  
D. Cibrik ◽  
...  
Keyword(s):  
Pancreas Transplant ◽  
Transplant Recipients ◽  
Cytomegalovirus Disease

CYTOMEGALOVIRUS DISEASE RECURRENCE AFTER GANCICLOVIR TREATMENT IN KIDNEY AND KIDNEY-PANCREAS TRANSPLANT RECIPIENTS

1999 ◽  
Vol 67 (1) ◽  
pp. 94-97 ◽  
Author(s):  
Abhinav Humar ◽  
Marc Uknis ◽  
Cassandra Carlone-Jambor ◽  
Rainer W. Gruessner ◽  
David L. Dunn ◽  
...  
Keyword(s):  
Disease Recurrence ◽  
Pancreas Transplant ◽  
Transplant Recipients ◽  
Cytomegalovirus Disease ◽  
Ganciclovir Treatment

scholarly journals Comparative Incidence and Outcomes of COVID-19 in Kidney or Kidney-Pancreas Transplant Recipients Versus Kidney or Kidney-Pancreas Waitlisted Patients: A Pilot Study

2020 ◽  
Author(s):  
Carlos Santos ◽  
Yoona Rhee ◽  
Edward Hollinger ◽  
Oyedolamu Olaitan ◽  
Erik Schadde ◽  
...  
Keyword(s):  
Pilot Study ◽  
Epidemiologic Studies ◽  
Pancreas Transplant ◽  
Transplant Recipients ◽  
Multicenter Studies ◽  
Mechanically Ventilated ◽  
Immunosuppressive Medications ◽  
The Impact ◽  
Insight Into ◽  
Immunocompetent Patients

Comparative COVID-19 epidemiologic studies between immunosuppressed and immunocompetent patients may provide insight into the impact of immunosuppressive medications on clinical outcomes. In this retrospective cohort pilot study, we determined the incidence and outcomes of COVID-19 in kidney or kidney-pancreas transplant recipients and kidney or kidney-pancreas waitlisted patients in our center. COVID-19 testing was performed in 63 of 537 kidney or kidney-pancreas transplanted patients, versus 43 of 383 kidney or kidney-pancreas waitlisted patients as of June 4, 2020 (12% versus 11%, p=0.81). COVID-19 was identified in 14 of 537 kidney or kidney-pancreas transplanted patients, versus 9 of 383 kidney or kidney-pancreas waitlisted patients (2.6% versus 2.3%, p=0.81). Hospitalization occurred in 11 of 14 transplanted patients, and 4 of 9 waitlisted patients with COVID-19 (79% versus 44%, p=0.18). Intensive care unit admission occurred in 5 of 14 transplanted patients, and 1 of 9 waitlisted patients with COVID-19 (36% versus 11%, p=0.34). Two transplanted patients with COVID-19 were mechanically ventilated and died, whereas no waitlisted patients with COVID-19 died or were mechanically ventilated. Our study provides preliminary data that can be used for power calculations to inform multicenter studies designed to validate these findings.

Tacrolimus for simultaneous kidney-pancreas transplant recipients

2006 ◽  
Author(s):  
Shu Shi Huang ◽  
Na Zhao ◽  
Shengfu Li ◽  
Dan Long ◽  
Xin Duan ◽  
...  
Keyword(s):  
Pancreas Transplant ◽  
Transplant Recipients

A Single-Center Experience With Tacrolimus LCP (Envarsus XR) in Pancreas Transplant Recipients

2017 ◽  
Vol 52 (4) ◽  
pp. 392-396
Author(s):  
L. Kerstenetzky ◽  
J. L. Descourouez ◽  
M. R. Jorgenson ◽  
D. C. Felix ◽  
D. A. Mandelbrot ◽  
...  
Keyword(s):  
Pancreas Transplant ◽  
Transplant Recipients ◽  
Single Center ◽  
Single Center Experience

scholarly journals Impact of valganciclovir prophylaxis duration on cytomegalovirus disease in high‐risk donor seropositive/recipient seronegative heart transplant recipients

2020 ◽  
Vol 22 (3) ◽  
Author(s):  
Hannah Imlay ◽  
Allison O. Dumitriu Carcoana ◽  
Cynthia E. Fisher ◽  
Beatrice Wong ◽  
Robert M. Rakita ◽  
...  
Keyword(s):  
High Risk ◽  
Heart Transplant ◽  
Transplant Recipients ◽  
Cytomegalovirus Disease ◽  
Heart Transplant Recipients

THU0479 Pilot Study of Bone Mass in Heart Transplant Recipients

2016 ◽  
Vol 75 (Suppl 2) ◽  
pp. 365.1-365
Author(s):  
L. Bautista Aguilar ◽  
A. Salmoral Chamizo ◽  
I. Gomez-Gracia ◽  
R. Jimenez Gasco ◽  
P. Font ◽  
...  
Keyword(s):  
Pilot Study ◽  
Bone Mass ◽  
Heart Transplant ◽  
Transplant Recipients ◽  
Heart Transplant Recipients

Baseline Quality of Life and Anxiety in Solid Organ Transplant Recipients: A Pilot Study

2006 ◽  
Vol 32 (12) ◽  
pp. 1480-1485 ◽  
Author(s):  
FIONA O'REILLY ◽  
CARMEN TRAYWICK ◽  
MICHELLE L. PENNIE ◽  
JOVONNE K. FOSTER ◽  
SUEPHY C. CHEN
Keyword(s):  
Quality Of Life ◽  
Pilot Study ◽  
Organ Transplant ◽  
Solid Organ Transplant ◽  
Solid Organ ◽  
Transplant Recipients ◽  
Organ Transplant Recipients ◽  
Solid Organ Transplant Recipients

Mineralocorticoid Receptor Blockade Reduced Oxidative Stress in Renal Transplant Recipients: A Double-Blind, Randomized Pilot Study

2013 ◽  
Vol 37 (5) ◽  
pp. 481-490 ◽  
Author(s):  
Marcos Ojeda-Cervantes ◽  
Jonatan Barrera-Chimal ◽  
Josefina Alberú ◽  
Rosalba Pérez-Villalva ◽  
Luis Eduardo Morales-Buenrostro ◽  
...  
Keyword(s):  
Oxidative Stress ◽  
Pilot Study ◽  
Renal Transplant ◽  
Mineralocorticoid Receptor ◽  
Renal Transplant Recipients ◽  
Receptor Blockade ◽  
Transplant Recipients ◽  
Double Blind ◽  
Mineralocorticoid Receptor Blockade
Sign in / Sign up

Export Citation Format

Share Document